Ortho Clinical Diagnostics VITROS 5600 Integrated System (15782)
Specialty: Toxicology / TDM
Welcome to the PulseAid listing for the Ortho Clinical Diagnostics VITROS 5600 Integrated System medical device. This device is used in the Toxicology / TDM healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the Toxicology / TDM healthcare specialty at the bottom of the page.
Analytes Measured/Detected and Complexity:
| ANALYTE | COMPLEXITY |
| Acetaminophen (K081543 | K954933) | MODERATE Effective Date: 2009-01-30 |
| Acid phosphatase (K081543 | K914167) | MODERATE Effective Date: 2011-02-02 |
| Albumin (K081543 | K023875) | MODERATE Effective Date: 2009-01-30 |
| Alkaline phosphatase (ALP) (K081543 | K833833) | MODERATE Effective Date: 2009-01-30 |
| Alpha-1-antitrypsin (K052819 | K052819) | MODERATE Effective Date: 2011-02-14 |
| Ammonia, plasma/serum (K081543 | K820723) | MODERATE Effective Date: 2009-01-30 |
| Amphetamines (K081543 | K062077) | MODERATE Effective Date: 2009-01-30 |
| Amylase (K081543 | K812027) | MODERATE Effective Date: 2009-01-30 |
| Apolipoprotein A1 (K081543 | K042521) | MODERATE Effective Date: 2011-02-02 |
| Apolipoprotein B (K081543 | K042521) | MODERATE Effective Date: 2011-02-02 |
| Aspartate aminotransferase (AST) (SGOT) (K081543 | K001679) | MODERATE Effective Date: 2009-01-30 |
| Barbiturates (K081543 | K062165) | MODERATE Effective Date: 2009-01-30 |
| Benzodiazepines (K081543 | K062285) | MODERATE Effective Date: 2009-01-30 |
| Bilirubin, direct (K081543 | K840606) | MODERATE Effective Date: 2009-01-30 |
| Bilirubin, neonatal (K081543 | K840606) | MODERATE Effective Date: 2009-01-30 |
| Bilirubin, total (K081543 | K840880) | MODERATE Effective Date: 2009-01-30 |
| Bilirubin, unbound (K081543 | K840606) | MODERATE Effective Date: 2009-01-30 |
| C-reactive protein (CRP) (K081543 | K041799) | MODERATE Effective Date: 2009-01-30 |
| Caffeine (K081543 | K042520) | MODERATE Effective Date: 2011-02-02 |
| Calcium, total (K081543 | K072440) | MODERATE Effective Date: 2009-01-30 |
| Cannabinoids (THC) (K081543 | K063164) | MODERATE Effective Date: 2009-01-30 |
| Carbamazepine (K081543 | K980283) | MODERATE Effective Date: 2009-01-30 |
| Carbon dioxide, total (CO2) (K081543 | K001133) | MODERATE Effective Date: 2009-01-30 |
| Carcinoembryonic antigen (CEA) (K081543 | K041322) | MODERATE Effective Date: 2009-01-30 |
| Chloride (K081543 | K071801) | MODERATE Effective Date: 2009-01-30 |
| Cholesterol (K081543 | K012593) | MODERATE Effective Date: 2011-02-02 |
| Cholinesterase (K081543 | K912217) | MODERATE Effective Date: 2009-01-30 |
| Cocaine metabolites (K081543 | K062123) | MODERATE Effective Date: 2009-01-30 |
| Collagen type I crosslink, N-telopeptides (NTX) (K081543 | K983674) | MODERATE Effective Date: 2011-02-02 |
| Complement C3 (K042494 | K042494) | MODERATE Effective Date: 2011-02-03 |
| Complement C4 (K042494 | K042494) | MODERATE Effective Date: 2011-02-03 |
| Cortisol (K081543 | K060480) | MODERATE Effective Date: 2011-02-02 |
| Cortisol, urine (extraction procedure) (K081543 | K060480) | HIGH Effective Date: 2011-02-02 |
| Creatine kinase (CK) (K081543 | K833833) | MODERATE Effective Date: 2009-01-30 |
| Creatine kinase MB fraction (CKMB) (K081543 | K993068) | MODERATE Effective Date: 2009-01-30 |
| Creatinine (K081543 | K063591) | MODERATE Effective Date: 2009-01-30 |
| Digoxin (K081543 | K942610) | MODERATE Effective Date: 2009-01-30 |
| Ethanol (alcohol) (K081543 | K934273) | MODERATE Effective Date: 2009-01-30 |
| Ferritin (K081543 | K973331) | MODERATE Effective Date: 2009-01-30 |
| Folate (folic acid) (K081543 | K001266) | MODERATE Effective Date: 2011-02-02 |
| Folate, red blood cell (RBC folate) (K081543 | K001266) | HIGH Effective Date: 2011-02-02 |
| Gentamicin (K081543 | K042479) | MODERATE Effective Date: 2009-01-30 |
| Glucose (K081543 | K955286) | MODERATE Effective Date: 2009-01-30 |
| Glucose, urine (K081543 | K955286) | MODERATE Effective Date: 2009-01-30 |
| Glycosylated Hemoglobin (Hgb A1c) (CR140355 | K142595) | MODERATE Effective Date: 2015-06-04 |
| hCG, beta, serum, quantitative (K081543 | K063720) | MODERATE Effective Date: 2009-01-30 |
| HDL cholesterol (K081543 | K042006) | MODERATE Effective Date: 2011-02-02 |
| Hepatitis A virus antibody (K081543 | K060678) | MODERATE Effective Date: 2009-01-30 |
| Homocysteine (K081543 | K061588) | MODERATE Effective Date: 2009-01-30 |
| Insulin (CR170306 | CR170306) | MODERATE Effective Date: 2017-07-07 |
| Iron (K081543 | K910143) | MODERATE Effective Date: 2009-01-30 |
| Iron binding capacity, total (K081543 | K052867) | MODERATE Effective Date: 2009-01-30 |
| LDL cholesterol (K081543 | K041720) | MODERATE Effective Date: 2011-02-02 |
| Lithium (K081543 | K924488) | MODERATE Effective Date: 2009-01-30 |
| Magnesium (K081543 | K023876) | MODERATE Effective Date: 2009-01-30 |
| Methadone (K081543 | K062637) | MODERATE Effective Date: 2009-01-30 |
| Myoglobin (K081543 | K033300) | MODERATE Effective Date: 2009-01-30 |
| N-Terminal pro brain natriuretic peptide (ProBNP) (K081543 | K060632) | MODERATE Effective Date: 2009-01-30 |
| Opiates (K081543 | K062460) | MODERATE Effective Date: 2009-01-30 |
| Parathyroid hormone – intact (K101921 | K101921) | MODERATE Effective Date: 2011-01-20 |
| Phencyclidine (PCP) (K081543 | K062094) | MODERATE Effective Date: 2009-01-30 |
| Phenobarbital (K081543 | K984288) | MODERATE Effective Date: 2009-01-30 |
| Phosphorus (K081543 | K932729) | MODERATE Effective Date: 2009-01-30 |
| Potassium (K081543 | K073157) | MODERATE Effective Date: 2009-01-30 |
| Rheumatoid factor (RF) (K041863 | K041863) | MODERATE Effective Date: 2011-02-03 |
| Salicylates (K081543 | K902356) | MODERATE Effective Date: 2009-01-30 |
| Sodium (K081543 | K081411) | MODERATE Effective Date: 2009-01-30 |
| Testosterone (K081543 | K983507) | MODERATE Effective Date: 2011-02-02 |
| Theophylline (K081543 | K861367) | MODERATE Effective Date: 2009-01-30 |
| Thyroxine (T4) (K081543 | K964721) | MODERATE Effective Date: 2009-01-30 |
| Thyroxine, free (FT4) (K081543 | K965142) | MODERATE Effective Date: 2009-01-30 |
| Tobramycin (K081543 | K043384) | MODERATE Effective Date: 2009-01-30 |
| Transferrin (K081543 | K042477) | MODERATE Effective Date: 2009-01-30 |
| Triglyceride (K081543 | K812029) | MODERATE Effective Date: 2011-02-02 |
| Troponin-I (cardiac) (K081543 | K062838) | MODERATE Effective Date: 2009-01-30 |
| Urea (BUN) (K081543 | K001885) | MODERATE Effective Date: 2009-01-30 |
| Uric acid (K081543 | K932728) | MODERATE Effective Date: 2009-01-30 |
| Uric acid, urine (K081543 | K932728) | MODERATE Effective Date: 2009-01-30 |
| Valproic acid (K081543 | K042476) | MODERATE Effective Date: 2009-01-30 |
| Vancomycin (K081543 | K043386) | MODERATE Effective Date: 2009-01-30 |
| Vitamin B12 (K081543 | K013899) | MODERATE Effective Date: 2011-02-02 |